Dr. Brammer on FDA Approval of Brentuximab Vedotin in CTCL

Video

In Partnership With:

Jonathan Brammer, MD, hematologist, Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, discusses the FDA approval of brentuximab vedotin (Adcetris) for the treatment of patients with cutaneous T-cell lymphoma (CTCL).

Jonathan Brammer, MD, hematologist, Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, discusses the FDA approval of brentuximab vedotin (Adcetris) for the treatment of patients with cutaneous T-cell lymphoma (CTCL).

Related Videos
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Related Content
Head and Neck Cancer

Quad Shot Radiation Plus Immunotherapy Improves Local Control in Advanced Head and Neck Cancer

March 16th 2024
Article
Alice Mims, MD, medical oncologist, associate professor, the Division of Hematology, The Ohio State University Comprehensive Cancer Center—James

Mims Expands on the Evaluation of Emavusertib in the TakeAim Leukemia Trial of AML and MDS

February 26th 2024
Podcast
David P. Carbone, MD, PhD, of The Ohio State University Comprehensive Cancer Center–James

Lung Specialist Finds His “Sweet Spot” at the Intersection of Medicine and Technology

January 1st 2024
Article
Matthew Lunning, DO, FACP

Lunning and Maddocks Talk Through Frontline MCL Management

January 22nd 2024
Podcast
Jennifer A. Woyach, MD

Pirtobrutinib Demonstrates Durable Efficacy in Covalent BTK Inhibitor–Pretreated CLL/SLL

December 10th 2023
Article
Andrew Srisuwananukorn, MD

AI Algorithm Effectively Differentiates Between pre-PMF/ET

December 9th 2023
Article